EA200001254A1 - Полипептид человеческого протеина с - Google Patents

Полипептид человеческого протеина с

Info

Publication number
EA200001254A1
EA200001254A1 EA200001254A EA200001254A EA200001254A1 EA 200001254 A1 EA200001254 A1 EA 200001254A1 EA 200001254 A EA200001254 A EA 200001254A EA 200001254 A EA200001254 A EA 200001254A EA 200001254 A1 EA200001254 A1 EA 200001254A1
Authority
EA
Eurasian Patent Office
Prior art keywords
human protein
protein polypeptide
isolated polypeptide
polypeptide
diseases
Prior art date
Application number
EA200001254A
Other languages
English (en)
Inventor
Лихуа Хуанг
Ральф Меридит Риджин
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200001254A1 publication Critical patent/EA200001254A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Описан выделенный полипептид человеческого протеина С с усеченной тяжелой цепью. Этот выделенный полипептид сохраняет биологическую активность человеческого протеина С дикого типа. Этот полипептид будет полезным при лечении сосудистых окклюзивных заболеваний, состояний, характеризующихся гиперкоагуляцией, тромботических заболеваний и болезненных состояний, предрасполагающих к тромбозу.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200001254A 1998-06-01 1999-06-01 Полипептид человеческого протеина с EA200001254A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8758598P 1998-06-01 1998-06-01
PCT/US1999/011969 WO1999063070A1 (en) 1998-06-01 1999-06-01 Human protein c polypeptide

Publications (1)

Publication Number Publication Date
EA200001254A1 true EA200001254A1 (ru) 2001-06-25

Family

ID=22206075

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200001254A EA200001254A1 (ru) 1998-06-01 1999-06-01 Полипептид человеческого протеина с

Country Status (25)

Country Link
US (1) US20040038288A1 (ru)
EP (1) EP1084235A4 (ru)
JP (1) JP2002517191A (ru)
KR (1) KR20010043941A (ru)
CN (1) CN1303428A (ru)
AR (1) AR020082A1 (ru)
AU (1) AU4409399A (ru)
BR (1) BR9910858A (ru)
CA (1) CA2330171A1 (ru)
CO (1) CO5070672A1 (ru)
DZ (1) DZ2803A1 (ru)
EA (1) EA200001254A1 (ru)
HR (1) HRP20000826A2 (ru)
HU (1) HUP0102014A3 (ru)
ID (1) ID27282A (ru)
IL (1) IL139595A0 (ru)
NO (1) NO20006091L (ru)
NZ (1) NZ507982A (ru)
PE (1) PE20000561A1 (ru)
PL (1) PL344349A1 (ru)
SK (1) SK17502000A3 (ru)
SV (1) SV1999000067A (ru)
TR (1) TR200003552T2 (ru)
WO (1) WO1999063070A1 (ru)
ZA (1) ZA200006647B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006025995A2 (en) * 2004-07-27 2006-03-09 The Regents Of The University Of California Compositions and methods using md-2 mutants and chimeric proteins
CN108159399B (zh) * 2017-12-29 2020-07-24 华中科技大学同济医学院附属同济医院 一种凝血蛋白酶aPC在防治糖尿病心肌病药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2728240B2 (ja) * 1988-07-26 1998-03-18 ヘキスト薬品工業株式会社 ヒトプロテインｃ変異体及びその製造方法
WO1991009960A1 (en) * 1989-12-29 1991-07-11 Zymogenetics, Inc. Hybrid protein c
WO1991012320A1 (en) * 1990-02-09 1991-08-22 Zymogenetics, Inc. Activated protein c with truncated light chain
JPH0564588A (ja) * 1991-08-14 1993-03-19 Teijin Ltd 短い重鎖を有するヒトプロテインｃおよび活性化ヒトプロテインｃ

Also Published As

Publication number Publication date
NZ507982A (en) 2004-01-30
BR9910858A (pt) 2001-03-06
IL139595A0 (en) 2002-02-10
NO20006091D0 (no) 2000-11-30
PL344349A1 (en) 2001-11-05
EP1084235A1 (en) 2001-03-21
CA2330171A1 (en) 1999-12-09
HUP0102014A2 (hu) 2001-10-28
EP1084235A4 (en) 2002-03-27
JP2002517191A (ja) 2002-06-18
CO5070672A1 (es) 2001-08-28
ID27282A (id) 2001-03-22
HUP0102014A3 (en) 2003-09-29
CN1303428A (zh) 2001-07-11
AR020082A1 (es) 2002-04-10
WO1999063070A1 (en) 1999-12-09
NO20006091L (no) 2001-01-31
DZ2803A1 (fr) 2003-12-01
ZA200006647B (en) 2001-11-15
HRP20000826A2 (en) 2001-10-31
PE20000561A1 (es) 2000-07-22
SK17502000A3 (sk) 2001-09-11
US20040038288A1 (en) 2004-02-26
KR20010043941A (ko) 2001-05-25
AU4409399A (en) 1999-12-20
SV1999000067A (es) 2000-07-06
TR200003552T2 (tr) 2001-05-21

Similar Documents

Publication Publication Date Title
DK308684A (da) Enzympraeparat til rensningsformaal
EA199900980A1 (ru) Улучшенные способы приготовления активированного белка с
ATE57474T1 (de) Ozonentkeimung von blut und blutprodukten.
DE69027990D1 (de) Kultur des wachstumsfaktors der vaskularen endothelialzellen und dns, die dafür kodiert
ES557100A0 (es) Un metodo de produccion de un polipeptido con actividad de proteina c humana en una celula huesped
DE3855970T2 (de) Verwendung von Amylin oder CGRP zur Behandlung des Diabetes mellitus
EA199700359A1 (ru) Пептиды и соединения, связывающиеся с тромбопоэтиновым рецептором
ES2074042T3 (es) Exotoxina recombinante de pseudomonas construccion de una inmunotoxina activa con efectos secundarios menores.
ATE262336T1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
EA200100749A1 (ru) Синтетические пептиды, обладающие поверхностной активностью, и их применение для приготовления синтетического сурфактанта
ES2037669T3 (es) Un procedimiento para preparar una sustancia que se une a la trombina.
Costa et al. Importance of metalloproteinases and macrophages in viper snake envenomation–induced local inflammation
KR890011606A (ko) 항응고제
MX9203879A (es) Muteina de il-6 con cisteina parcialmente suprimida.
DK0383417T3 (da) Flagmusespyt-plasminogenaktivator v-PAalfa1
EA200001254A1 (ru) Полипептид человеческого протеина с
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
DE60108076D1 (de) Protein c derivate
ATE55059T1 (de) Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen.
EA200401390A1 (ru) N-ацетилглюкозамин-6-фосфатдеацетилаза человека, взаимодействующая с каспазой-8, и способы ее применения
ES2070134T3 (es) Inhibidores de lisil oxidasa.
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
WO2000068264A3 (en) A peptide inhibitor of fibrinogen blood clotting
ATE62789T1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
GB2011910A (en) Process for the Treatment of Proteinaceous Materials of Animal Origin